ZNF384
| Zinc finger protein 384 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Identifiers | |||||||||||||
| Symbols | ZNF384 ; CAGH1; CAGH1A; CIZ; ERDA2; NMP4; NP; TNRC1 | ||||||||||||
| External IDs | OMIM: 609951 MGI: 2443203 HomoloGene: 15849 GeneCards: ZNF384 Gene | ||||||||||||
| |||||||||||||
| RNA expression pattern | |||||||||||||
 | |||||||||||||
| More reference expression data | |||||||||||||
| Orthologs | |||||||||||||
| Species | Human | Mouse | |||||||||||
| Entrez | 171017 | 269800 | |||||||||||
| Ensembl | ENSG00000126746 | ENSMUSG00000038346 | |||||||||||
| UniProt | Q8TF68 | E9Q1A5 | |||||||||||
| RefSeq (mRNA) | NM_001039916 | NM_001252083 | |||||||||||
| RefSeq (protein) | NP_001035009 | NP_001239012 | |||||||||||
| Location (UCSC) | Chr 12: 6.78 – 6.8 Mb | Chr 6: 125.01 – 125.04 Mb | |||||||||||
| PubMed search | |||||||||||||
Zinc finger protein 384 is a protein that in humans is encoded by the ZNF384 gene.[1][2][3]
DISCONTINUED: LocusID 10601 was defined by accessions U80748 and U80760 which appear to have been annotated on the complementary strand. Splice junction sequences and EST evidence suggest that the more likely transcript in this region is AB070238.[3]
References
- ↑ Margolis RL, Abraham MR, Gatchell SB, Li SH, Kidwai AS, Breschel TS, Stine OC, Callahan C, McInnis MG, Ross CA (Jul 1997). "cDNAs with long CAG trinucleotide repeats from human brain". Hum Genet 100 (1): 114–22. doi:10.1007/s004390050476. PMID 9225980.
- ↑ Thunyakitpisal P, Alvarez M, Tokunaga K, Onyia JE, Hock J, Ohashi N, Feister H, Rhodes SJ, Bidwell JP (Jan 2001). "Cloning and functional analysis of a family of nuclear matrix transcription factors (NP/NMP4) that regulate type I collagen expression in osteoblasts". J Bone Miner Res 16 (1): 10–23. doi:10.1359/jbmr.2001.16.1.10. PMID 11149472.
- ↑ 3.0 3.1 "Entrez Gene: ZNF384 zinc finger protein 384".
Further reading
- Matsuo MY, Asakawa S, Shimizu N et al. (2002). "Nucleotide sequence of the MHC class I genomic region of a teleost, the medaka (Oryzias latipes)". Immunogenetics 53 (10–11): 930–40. doi:10.1007/s00251-001-0427-3. PMID 11862394.
- Graflund M, Sorbe B, Karlsson M (2002). "MIB-1, p53, bcl-2, and WAF-1 expression in pelvic lymph nodes and primary tumors in early stage cervical carcinomas: correlation with clinical outcome". Int. J. Oncol. 20 (5): 1041–7. doi:10.3892/ijo.20.5.1041. PMID 11956602.
- Martini A, La Starza R, Janssen H et al. (2002). "Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia". Cancer Res. 62 (19): 5408–12. PMID 12359745.
- Strausberg RL, Feingold EA, Grouse LH et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Ota T, Suzuki Y, Nishikawa T et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Suzuki Y, Yamashita R, Shirota M et al. (2004). "Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions". Genome Res. 14 (9): 1711–8. doi:10.1101/gr.2435604. PMC 515316. PMID 15342556.
- La Starza R, Aventin A, Crescenzi B et al. (2005). "CIZ gene rearrangements in acute leukemia: report of a diagnostic FISH assay and clinical features of nine patients". Leukemia 19 (9): 1696–9. doi:10.1038/sj.leu.2403842. PMID 15990865.
- Janssen H, Marynen P (2006). "Interaction partners for human ZNF384/CIZ/NMP4--zyxin as a mediator for p130CAS signaling?". Exp. Cell Res. 312 (7): 1194–204. doi:10.1016/j.yexcr.2006.02.001. PMID 16510139.
External links
- ZNF384 protein, human at the US National Library of Medicine Medical Subject Headings (MeSH)
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||